Who makes E39 peptide vaccine?

E39 peptide vaccine is developed by COL George Peoples, MD, FACS.

What development phase is E39 peptide vaccine in?

E39 peptide vaccine is in Phase 1.

Last reviewed 2026-04-19 · How we verify

E39 peptide vaccine

COL George Peoples, MD, FACS · Phase 1 active Biologic

At a glance

Generic name	E39 peptide vaccine
Also known as	E39 peptide (EIWTHSYKV, Folate Binding Protein, 191-199), GM-CSF (Sargramostim)
Sponsor	COL George Peoples, MD, FACS
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

E39 peptide vaccine CI brief — competitive landscape report
E39 peptide vaccine updates RSS · CI watch RSS
COL George Peoples, MD, FACS portfolio CI